We next examined individual genes and find that in luminal A breast cancers ENG, TGFBR3, INHA, and INHBA, were better performing as compared to INHBB particularly for taxane or anthracycline based chemotherapy regimens. The gene discussed is INHA; the disease is breast carcinoma.